Literature DB >> 16418517

IGF1 gene polymorphism and risk for hereditary nonpolyposis colorectal cancer.

Maja Zecevic1, Christopher I Amos, Xiangjun Gu, Imelda M Campos, J Shawn Jones, Patrick M Lynch, Miguel A Rodriguez-Bigas, Marsha L Frazier.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant disorder caused by germline mutations in DNA mismatch repair (MMR) genes. Insulin-like growth factor-I (IGF-I) is involved in colorectal carcinogenesis, and elevated plasma IGF-I levels are associated with sporadic colorectal cancer (CRC) risk. We investigated the relationship between IGF1 promoter cytosine-adenine (CA) dinucleotide-repeat polymorphism length and CRC risk in 121 MMR gene mutation carriers using Cox regression and Kaplan-Meier analysis. All statistical tests were two-sided. Time to onset for CRC increased for each decrease in CA-repeat number (median = 19 repeats, range = 12-22 repeats; hazard ratio [HR] = 1.17, 95% confidence interval [CI] = 1.05 to 1.31; P = .006). Patients carrying a CA(< or = 17) repeat allele had a statistically significantly higher CRC risk (HR = 2.36; 95% CI = 1.28 to 4.36; P = .006) than all others and were younger at onset (44 years versus 56.5 years; P = .023). These findings indicate a statistically significant association between shorter IGF1 CA-repeat lengths and increased risk for CRC in HNPCC. This is the first report, to our knowledge, to show that IGF1 variant genotypes modify risk of a hereditary form of cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16418517     DOI: 10.1093/jnci/djj016

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  22 in total

1.  Evaluation of Lynch syndrome modifier genes in 748 MMR mutation carriers.

Authors:  Solene Houlle; Françoise Charbonnier; Estelle Houivet; Julie Tinat; Marie-Pierre Buisine; Olivier Caron; Jacques Benichou; Stéphanie Baert-Desurmont; Thierry Frebourg
Journal:  Eur J Hum Genet       Date:  2011-03-16       Impact factor: 4.246

2.  Association of insulin-like growth factor-I receptor polymorphism with colorectal cancer development.

Authors:  Noyko S Stanilov; Iliya A Karakolev; Tashko S Deliysky; Jovcho P Jovchev; Spaska A Stanilova
Journal:  Mol Biol Rep       Date:  2014-09-05       Impact factor: 2.316

3.  Genes in the insulin and insulin-like growth factor pathway and odds of metachronous colorectal neoplasia.

Authors:  Elizabeth C LeRoy; Jason H Moore; Chengcheng Hu; María Elena Martínez; Peter Lance; David Duggan; Patricia A Thompson
Journal:  Hum Genet       Date:  2011-01-11       Impact factor: 4.132

4.  IGF gene polymorphisms and breast cancer in African-American and Hispanic women.

Authors:  Marianna Sarkissyan; Dhruva Kumar Mishra; Yanyuan Wu; Xiying Shang; Suren Sarkissyan; Jaydutt V Vadgama
Journal:  Int J Oncol       Date:  2011-03-30       Impact factor: 5.650

5.  Functional polymorphisms in the insulin-like binding protein-3 gene may modulate susceptibility to differentiated thyroid carcinoma in Caucasian Americans.

Authors:  Li Xu; Liliana Mugartegui; Guojun Li; Nicholas J Sarlis; Qingyi Wei; Mark E Zafereo; Erich M Sturgis
Journal:  Mol Carcinog       Date:  2012-03-13       Impact factor: 4.784

6.  Chronic inflammation, colorectal cancer and gene polymorphisms.

Authors:  C Richard Boland
Journal:  Dig Dis       Date:  2010-11-18       Impact factor: 2.404

7.  A functional variant of IC53 correlates with the late onset of colorectal cancer.

Authors:  Jingzhou Chen; Yi Shi; Ziyu Li; Hui Yu; Yu Han; Xiaojian Wang; Kai Sun; Tao Yang; Kejia Lou; Yan Song; Yinhui Zhang; Yisong Zhen; Guiguo Zhang; Ying Hu; Jiafu Ji; Rutai Hui
Journal:  Mol Med       Date:  2011-03-02       Impact factor: 6.354

8.  Genetic variants in the cell cycle control pathways contribute to early onset colorectal cancer in Lynch syndrome.

Authors:  Jinyun Chen; Carol J Etzel; Christopher I Amos; Qing Zhang; Nancy Viscofsky; Noralane M Lindor; Patrick M Lynch; Marsha L Frazier
Journal:  Cancer Causes Control       Date:  2009-08-19       Impact factor: 2.506

9.  IGF and insulin receptor signaling in breast cancer.

Authors:  Antonino Belfiore; Francesco Frasca
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-19       Impact factor: 2.673

10.  Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Shruti G Dighe; Jianhong Chen; Li Yan; Qianchuan He; Puya Gharahkhani; Lynn Onstad; David M Levine; Claire Palles; Weimin Ye; Marilie D Gammon; Prasad G Iyer; Lesley A Anderson; Geoffrey Liu; Anna H Wu; James Y Dai; Wong-Ho Chow; Harvey A Risch; Jesper Lagergren; Nicholas J Shaheen; Leslie Bernstein; Douglas A Corley; Hans Prenen; John deCaestecker; David MacDonald; Paul Moayyedi; Hugh Barr; Sharon B Love; Laura Chegwidden; Stephen Attwood; Peter Watson; Rebecca Harrison; Katja Ott; Susanne Moebus; Marino Venerito; Hauke Lang; Rupert Mayershofer; Michael Knapp; Lothar Veits; Christian Gerges; Josef Weismüller; Ines Gockel; Yogesh Vashist; Markus M Nöthen; Jakob R Izbicki; Hendrik Manner; Horst Neuhaus; Thomas Rösch; Anne C Böhmer; Arnulf H Hölscher; Mario Anders; Oliver Pech; Brigitte Schumacher; Claudia Schmidt; Thomas Schmidt; Tania Noder; Dietmar Lorenz; Michael Vieth; Andrea May; Timo Hess; Nicole Kreuser; Jessica Becker; Christian Ell; Christine B Ambrosone; Kirsten B Moysich; Stuart MacGregor; Ian Tomlinson; David C Whiteman; Janusz Jankowski; Johannes Schumacher; Thomas L Vaughan; Margaret M Madeleine; Laura J Hardie; Matthew F Buas
Journal:  Carcinogenesis       Date:  2021-04-17       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.